skip to main content

Dabigatran monitored dosage system — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

HardDispensing and SupplyDabigatran monitored dosage systemGPhC CRA

A care home requests that dabigatran capsules be removed from original packaging and placed into a monitored dosage system for four weeks. The patient has AF and eGFR 55mL/min/1.73m2. What is the legal classification/requirement?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: C — Check stability guidance and avoid repackaging if the product must remain in original packaging.

Some medicines, including dabigatran capsules, have important packaging requirements related to moisture protection. Repackaging into an MDS may compromise stability and safety unless reliable product-specific guidance supports it. Capsules should not be opened because exposure can alter drug delivery and bleeding risk.

Reference: BNF; SmPC; MEP